About Cipher Surgical

Our Mission

We are a British company established in 2010 with the goal of improving the efficiency and safety of minimally invasive surgery through the development and commercialisation of products that maintain uncompromised surgical vision.

The OpClear® platform, launched in 2013, shields the laparoscope’s lens from condensation and particulates through an intelligent CO2 flow at its tip and removes visual obstructions with an on demand CO2 and saline lens wash, allowing procedures to continue with minimal disruption.

Cipher Surgical is focused on research and development, investing 35% of expenditure annually. Projects include clinical research to validate the impact of the OpClear platform on patient outcomes. This work enables physicians and hospitals to make evidence-based decisions.

Our goal is to make in-situ lens cleaning the standard of care by scientifically demonstrating its true value to healthcare systems worldwide.

Company Timeline

Cipher Surgical established
1st generation OpClear design validated
UK and Europe patents granted
Cipher Surgical awarded ISO 13485 certification



CE mark granted for 1st generation OpClear



Japan patent granted

First in patient use of OpClear in the UK
Development of 2nd generation OpClear (with intelligent Control Unit and use of saline)
CE Mark granted for the 2nd generation OpClear control unit to provide automated intelligent CO2 flow and saline wash at the tip of the laparoscope

UK clinical evaluations
OpClear receives US regulatory clearance (FDA 510k)



OpClear platform gains Japan regulatory clearance
MDSAP certificate granted



UK Launch



US Clinical Evaluations
Japan clinical evaluations



US logistics established
What do the
experts say?
Interested in OpClear?
Call +44 (0) 2477 170 700 or send a message on the form below
Product evaluation
Cost savings
Training
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.